EQL Pharma AB Financial Overview
EQL Pharma AB's market cap is currently €133.29M. The company's EPS TTM is €-0.0100375; its P/E ratio is 48.90; EQL Pharma AB is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is €0.01. See an overview of income statement, balance sheet, and cash flow financials.
